SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-181337
Filing Date
2023-07-03
Accepted
2023-07-03 16:01:55
Documents
12
Period of Report
2023-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d524590d8k.htm   iXBRL 8-K 24370
  Complete submission text file 0001193125-23-181337.txt   150312

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA idya-20230629.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20230629_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20230629_pre.xml EX-101.PRE 11711
6 EXTRACTED XBRL INSTANCE DOCUMENT d524590d8k_htm.xml XML 3482
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 231065275
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences